18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

NCT00654745 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Hypertension

Interventions

DRUG: Amlodipine
DRUG: amlodipine / olmesartan medoxomil combination
DRUG: Hydrochlorothiazide

Sponsor

Daiichi Sankyo